Evotec Se (EVTCY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | EVTCY | CRNX | ORKA | ||
| Company | Evotec Se | Crinetics Pharmaceuticals Inc | Oruka Therapeutics Inc | ||
| Price Information | |||||
| Exchange | OTC US | NASDAQ | NASDAQ | ||
| Open | 23.0201 | 84.38 | 106.02 | ||
| High | 23.0201 | 84.65 | 108.40 | ||
| Low | 22.9600 | 84.36 | 105.10 | ||
| Last | 22.9600 | 84.62 | 107.52 | ||
| Change | -0.0100 | +0.18 | -0.60 | ||
| Percent Change | -0.04% | +0.21% | -0.55% | ||
| Volume | 300 | 605,807 | 221,936 | ||
| 20-Day Average Volume | 975 | 2,524,554 | 744,557 | ||
| Previous | 22.9700 | 84.44 | 108.12 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 24.7439 | 83.96 | 97.28 | ||
| 20-Day Raw Stochastic | 9.20% | 92.34% | 90.81% | ||
| 20-Day Relative Strength | 46.47 | 87.74 | 67.49 | ||
| Weighted Alpha | +45.65 | +50.65 | +514.06 | ||
| Today's Opinion | 56% Buy | 100% Buy | 100% Buy | ||
| Yesterday's Opinion | 56% Buy | 100% Buy | 100% Buy | ||
| Last Month's Opinion | 100% Buy | 88% Buy | 88% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -4.13% since 10/27/21 | +0.64% since 08/07/26 | +8.46% since 08/07/26 | ||
| Low | 22.9600 on 11/03/21 | 83.96 on 08/10/26 | 95.50 on 08/10/26 | ||
| High | 24.8200 on 10/28/21 | 84.71 on 08/13/26 | 109.42 on 08/12/26 | ||
| 1-Month | |||||
| %Chg | -3.38% since 09/29/21 | +1.08% since 07/14/26 | +22.54% since 07/14/26 | ||
| Low | 22.5944 on 10/07/21 | 83.47 on 07/31/26 | 80.72 on 07/17/26 | ||
| High | 26.5700 on 10/21/21 | 84.71 on 08/13/26 | 109.42 on 08/12/26 | ||
| 3-Month | |||||
| %Chg | +13.03% since 08/02/21 | +120.87% since 05/14/26 | +67.74% since 05/14/26 | ||
| Low | 21.0925 on 08/04/21 | 32.30 on 06/02/26 | 53.62 on 06/01/26 | ||
| High | 26.5700 on 10/21/21 | 84.71 on 08/13/26 | 109.42 on 08/12/26 | ||
| 6-Month | |||||
| %Chg | +9.73% since 04/30/21 | +98.16% since 02/13/26 | +232.77% since 02/13/26 | ||
| Low | 20.1250 on 05/12/21 | 32.30 on 06/02/26 | 31.08 on 02/19/26 | ||
| High | 26.5700 on 10/21/21 | 84.71 on 08/13/26 | 109.42 on 08/12/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 7,581,874 | 8,956,129 | 7,158,625 | ||
| Shares Outstanding, K | 330,221 | 106,065 | 66,210 | ||
| Annual Sales, $M | 572,210,000 | 7,700,000 | 0 | ||
| Annual Net Income, $M | 7,140,000 | -465,320,000 | -105,430,000 | ||
| Last Qtr Sales, $M | 166,520,000 | 25,120,000 | 0 | ||
| Last Qtr Income, $M | 72,310,000 | -120,860,000 | -31,820,000 | ||
| 60-Month Beta | 0.98 | 0.12 | -0.34 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A | -1.14 on 08/03/26 | -0.55 on 08/10/26 | ||
| Latest Earnings Date | 11/11/21 | 11/05/26 | 11/11/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividend Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 56.02 | 0.00 | 0.00 | ||